Filing Details
- Accession Number:
- 0001415889-23-006620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-18 17:49:36
- Reporting Period:
- 2023-04-14
- Accepted Time:
- 2023-04-18 17:49:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1820036 | A Richard Graham | C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080 | Svp, Research & Development | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2023-04-14 | 2,323 | $11.88 | 369,494 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.
Billionaire Hedge Funds
